U.S. Patient Access
Gilead Patient Support Programs
Our U.S. patient support programs help make Gilead therapies accessible for individuals who need information regarding insurance and financial support. These programs include:
Advancing Access®
Gilead HIV Treatment, HIV Prevention and COVID-19 Treatment
Phone: +1-800-226-2056
+1-800-226-2056
Cayston Access Program®
Gilead Cystic Fibrosis Product
Phone: +1-877-722-9786
+1-877-722-9786
Letairis Education and Access Program
Gilead Pulmonary Arterial Hypertension (PAH)
Phone: +1-866-664-5327
+1-866-664-5327
Support Path®
Gilead Hepatitis B and C
Phone: +1-855-769-7284
+1-855-769-7284
Trodelvy Access Support
Gilead Oncology
Phone: +1-844-876-3358
+1-844-876-3358
Zydelig AccessConnect™
Gilead Oncology
Phone: +1-844-622-2377
+1-844-622-2377
Kite Konnect™
Kite Oncology
Phone: +1-844-454-KITE (5483).
+1-844-454-KITE (5483)
The integrity of our patient support programs is critical to their sustainability. Any concerns about potential fraudulent activity involving patient support programs can be reported here.
Advancing Access®
Gilead’s Advancing Access program helps patients understand their coverage and identify financial support options to access their Gilead HIV treatment, HIV prevention medication and COVID-19 medication Veklury®, remdesivir. The program offerings include:
- Access to program specialists who can help answer insurance-related questions and provide information regarding coverage options.
- Advancing Access co-pay coupon program, which provides co-pay support for eligible people on HIV treatment and HIV prevention medication with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $0 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Additional restrictions may apply.
- Veklury co-pay support for eligible people with commercial insurance who need help paying for their out-of-pocket medicine costs. The co-pay coupon program is not available for people enrolled in government healthcare programs, such as Medicare and Medicaid.
- Advancing Access patient assistance program, which provides Gilead medicines at no cost for qualified patients who meet the program’s eligibility criteria.
- To find a participating retail pharmacy, click here.
- Click here if you are a participating pharmacy and need to submit an appeal for claim reimbursement.
- Providing information and education about support that may be available to hospitals treating patients with Veklury® through Advancing Access.
- Responding to general questions and inquiries from facilities, healthcare providers, and patients regarding Veklury and product accessibility.
- Providing coding and reimbursement information of general applicability.
- Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide)
- Complera® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
- Descovy® (emtricitabine/tenofovir alafenamide)
- Emtriva® (emtricitabine)
- Genvoya® (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide)
- Odefsey® (emtricitabine/rilpivirine/tenofovir alafenamide)
- Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate)
- Truvada® (emtricitabine/tenofovir disoproxil fumarate)
- Tybost® (cobicistat)
- Veklury® (remdesivir)
We recognize that hospital systems have established ways to support patients in the hospital with reimbursement and payment-related concerns. Advancing Access can support those efforts by:
The Advancing Access program supports the following medicines:
To learn more about the Advancing Access program, visit www.GileadAdvancingAccess.com or call 1-800-226-2056, Monday through Friday between 9 a.m. and 8 p.m. EST.
Cayston Access Program®
The Cayston Access Program helps patients understand their coverage and identify financial support options to access Cayston® (aztreonam for inhalation solution). The program offerings include:
- Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
- Provide Information about authorized distributors (i.e. participating specialty pharmacies).
- Cayston co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $10 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid.
- Referral to the Cayston patient assistance program, which provides Cayston at no cost for qualified patients who meet the program’s eligibility criteria.
To learn more about the Cayston Access Program, visit https://www.cayston.com/ or call
Letairis Education and Access Program
The Letairis Education and Access Program (LEAP) helps patients understand their coverage and identify financial support options to access Letairis® (ambrisentan). The program offerings include:
- Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
- Information about authorized distributors (i.e. participating specialty pharmacies).
- Letairis co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $5 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid.
- Referral to the Patient Assistance Solutions™ program, which provides Letairis at no cost for qualified patients who meet the program’s eligibility criteria.
To learn more about LEAP, visit https://www.letairis.com/patients/ or call 1-866-664-5327 1-866-664-5327, Monday through Friday between 8 a.m. and 8 p.m. EST.
Support Path®
The Support Path program helps patients understand their coverage and identify financial support options to access their Gilead hepatitis C (HCV) and hepatitis B (HBV) medicine. The program offerings include:
- Access to program navigators who can help answer insurance-related information and provide questions regarding coverage options.
- Access to a nursing support line.
- Gilead HCV and HBV co-pay coupon programs, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $5 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid.
- Support Path patient assistance program, which provides Gilead HCV and HBV medicines at no cost for qualified patients who meet the program’s eligibility criteria.
The Support Path program supports the following medicines:
- Epclusa® (sofosbuvir/velpatasvir)
- Harvoni® (ledipasvir/sofosbuvir)
- Sovaldi® (sofosbuvir)
- Vosevi® (sofosbuvir/velpatasvir/voxilaprevir)
- Vemlidy® (tenofovir alafenamide)
To learn more about Support Path, visit https://www.mysupportpath.com or call
Trodelvy Access Support
The Trodelvy® Access Support program helps patients understand their coverage and identify financial support options to access Trodelvy® (sacituzumab govitecan-hziy). The program offerings include:
- Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
- Trodelvy Savings Program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. The co-pay card is not available for people enrolled in government healthcare prescription drug programs, such as Medicare and Medicaid.
- Trodelvy patient assistance program, which provides Trodelvy at no cost for qualified patients who meet the program’s eligibility criteria.
To learn more about Trodelvy Access Support, visit www.trodelvy.com.
Zydelig AccessConnect™
The Zydelig AccessConnect program helps patients understand their coverage and identify financial support options to access Zydelig® (idelalisib). The program offerings include:
- Access to case managers to help answer insurance-related questions and provide information regarding coverage options.
- Information about authorized distributors (i.e. participating specialty pharmacies).
- Zydelig co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $5 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid.
- Zydelig QuickStart program, which provides a 30-day supply of medicine at no cost for qualified patients who are experiencing insurance coverage delays (restrictions apply).
- Referral to the Zydelig patient assistance program, which provides Zydelig at no cost for qualified patients who meet the program’s eligibility criteria.
To learn more about Zydelig AccessConnect, visit www.zydeligaccessconnect.com or call
